Definitive Contract 75F40122C00150
Award Date
9/27/22
Potential Completion Date
12/23/24
Potential Value
$1M
Federal Agency
Food and Drug Administration
Awardee
Labstat International Inc.
Ultimate Awardee
Not listed
PSC Category
B537 - Special Studies/Analysis- Medical/Health
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Labstat International Inc., a for-profit limited liability company based in Canada. The $619,328.55 contract is for the chemical and physical characterization of pod and disposable e-cigarette aerosol. This order is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract held by Labstat...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,122,157.92 firm fixed price delivery order contract to Labstat International Inc., a foreign-owned for-profit organization, to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products. This contract is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract with Labstat to provide tobacco laboratory services...
This is a $1,215,324.40 Firm Fixed Price Delivery Order issued by the Food and Drug Administration (FDA) to Labstat International Inc., a leading analytical testing laboratory in Kitchener, Ontario. The contract is for Tobacco Lab Analysis Services and is part of a larger $45 million Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded to Labstat to provide laboratory services in support of the FDA's regulatory oversight of tobacco products. The contract covers a range of technical...
The U.S. Food and Drug Administration (FDA) awarded a $1,366,003.00 firm fixed-price delivery order contract to Research Triangle Institute (RTI International), a non-profit research organization, to determine the correlation between endotoxin and D-glucan concentration and microbial counts in open e-liquids. The contract has a period of performance through February 16, 2026 and was competitively awarded without any set-asides. RTI International is an experienced federal contractor, holding a...
This federal contract award to Labstat International Inc., a leading analytical testing laboratory, is for a stability study of cigarette tobacco filler on behalf of the Food and Drug Administration (FDA). The firm fixed price delivery order is valued at $112,994.60 and has a completion date of June 13, 2016. Labstat has been awarded multiple prior contracts from the FDA to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products in support...
The U.S. Food and Drug Administration (FDA) awarded a $437,684.94 firm fixed price delivery order to Labstat International Inc., a leading analytical testing laboratory, to provide tobacco lab analysis services. The scope includes generating and quantitating benzo[a]pyrene, tar, nicotine, and carbon monoxide from pipe tobacco mainstream smoke under a new smoking regimen. This delivery order is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract...
This is a firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) for $679,680.00. The contract is part of a larger In Vivo Toxicology of Tobacco 2015-2020 Indefinite Delivery, Indefinite Quantity (IDIQ) contract. Under this task order, LBERI will conduct an assessment of tobacco products and tobacco product constituents' genetic toxicology using in vitro assays to compare the...
The U.S. Food and Drug Administration (FDA) awarded a $653,000.00 firm-fixed-price purchase order to Tamarind Media LIMITED, a for-profit organization based in the United Kingdom. The contract is to provide the FDA with deidentified raw data and information from existing 2015-2019 surveys of U.S. vape shops and consumers, including the "US Vape Store Survey" and the "US Vape Product Consumer Survey" conducted by ECigIntelligence. This requirement supports the FDA's ongoing...
This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency, to Cerulean Corporation, a foreign-owned for-profit organization, for an Electronic Cigarette Testing Instrument. The firm-fixed-price purchase order has a ceiling value of $96,865.72 and a completion date of February 16, 2022. The contract has no set-aside designation. Based on the description of the product being procured, this award appears to be in support of the FDA's efforts to regulate and...
This is a delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a non-profit organization, for a project titled "CYTOTOXICITY OF COMMON SOLVENTS USED IN LIQUID NICOTINE FORMULATIONS". The contract has a potential value of $1,149,919.00 and a completion date of April 15, 2021. This delivery order is part of a larger indefinite delivery/indefinite quantity...